A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotnergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease

Congratulations to:

  • Bérénice Hatat,
  • Samir Yahiaoui,
  • Cédric Lecoutey,
  • Audrey Davis,
  • Thomas Freret,
  • Michel Boulouard,
  • Sylvie Claeysen,
  • Christophe Rochais,
  • and Patrick Dallemagne 

for publishing a new article in Frontiers in Aging Neuroscience using our actimeter.

Published: 2020, June 19th